Q: Does a Notice of Privacy Practices (NPP) have to be included in a lobby or just handed out to patients during admission? What are good practices generally with the NPP?
Q: I'm told, although I'm not convinced, that our payment for Keytruda is denied by Anthem when we use ICD-10-CM code Z51.11 (encounter for antineoplastic chemotherapy) first followed by the code for cancer, i.e., C34.12 (malignant neoplasm of upper lobe, left bronchus or lung). I reviewed the coding guidelines again and that is our instruction. Does anyone have experience with this issue?
Q: A patient presents for routine obstetrical (OB) care following a vaginal delivery. During the visit, the provider performs a postpartum depression screening. Should the depression screening be charged separately from the global OB visit service?
Q: I read that CMS changed the scope of work for the Beneficiary and Family Centered Care Quality Improvement Organizations (BFCC-QIO) Livanta and Kepro recently. What impact has that had on hospitals?